These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19300620)

  • 41. [Anticonvulsants and antipsychotics in the treatment of bipolar disorder].
    Moreno RA; Moreno DH; Soares MB; Ratzke R
    Braz J Psychiatry; 2004 Oct; 26 Suppl 3():37-43. PubMed ID: 15597138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.
    Dando TM; Keating GM
    Drugs; 2005; 65(17):2533-51. PubMed ID: 16296876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treating mixed mania/hypomania: a review and synthesis of the evidence.
    Takeshima M
    CNS Spectr; 2017 Apr; 22(2):177-185. PubMed ID: 28004626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidepressant treatment for acute bipolar depression: an update.
    Amit BH; Weizman A
    Depress Res Treat; 2012; 2012():684725. PubMed ID: 22319648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
    Yatham LN; Kennedy SH; Schaffer A; Parikh SV; Beaulieu S; O'Donovan C; MacQueen G; McIntyre RS; Sharma V; Ravindran A; Young LT; Young AH; Alda M; Milev R; Vieta E; Calabrese JR; Berk M; Ha K; Kapczinski F
    Bipolar Disord; 2009 May; 11(3):225-55. PubMed ID: 19419382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of bipolar mania with atypical antipsychotics.
    Chengappa KN; Suppes T; Berk M
    Expert Rev Neurother; 2004 Nov; 4(6 Suppl 2):S17-25. PubMed ID: 16279862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders.
    Akiskal HS; Bourgeois ML; Angst J; Post R; Möller H; Hirschfeld R
    J Affect Disord; 2000 Sep; 59 Suppl 1():S5-S30. PubMed ID: 11121824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New Developments in the Use of Atypical Antipsychotics in the Treatment of Bipolar Disorder: a Systematic Review of Recent Randomized Controlled Trials.
    Keramatian K; Chakrabarty T; Saraf G; Yatham LN
    Curr Psychiatry Rep; 2021 May; 23(7):39. PubMed ID: 33963957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bipolar depression: diagnostic and treatment considerations.
    Thase ME
    Dev Psychopathol; 2006; 18(4):1213-30. PubMed ID: 17064435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of atypical antipsychotics in bipolar depression and anxiety disorders.
    McIntyre R; Katzman M
    Bipolar Disord; 2003; 5 Suppl 2():20-35. PubMed ID: 14700010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical predictors of acute response with quetiapine in psychotic mood disorders.
    Zarate CA; Rothschild A; Fletcher KE; Madrid A; Zapatel J
    J Clin Psychiatry; 2000 Mar; 61(3):185-9. PubMed ID: 10817103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder.
    Mundo E; Cattaneo E; Zanoni S; Altamura AC
    Neuropsychiatr Dis Treat; 2006 Jun; 2(2):139-48. PubMed ID: 19412458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder.
    Young AH; McElroy SL; Olausson B; Paulsson B; ;
    World J Biol Psychiatry; 2014 Feb; 15(2):96-112. PubMed ID: 22404704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of mixed bipolar states.
    Fountoulakis KN; Kontis D; Gonda X; Siamouli M; Yatham LN
    Int J Neuropsychopharmacol; 2012 Aug; 15(7):1015-26. PubMed ID: 22217434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics.
    Selle V; Schalkwijk S; Vázquez GH; Baldessarini RJ
    Pharmacopsychiatry; 2014 Mar; 47(2):43-52. PubMed ID: 24549862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Migraine headache and bipolar disorder comorbidity: A systematic review of the literature and clinical implications.
    Leo RJ; Singh J
    Scand J Pain; 2016 Apr; 11():136-145. PubMed ID: 28850455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.